NP

Nevilkumar Pratapbhai Mori

Active Director Director DIN 11533153
DIN 11533153 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nevilkumar Pratapbhai Mori

Data last updated:

Nevilkumar Pratapbhai Mori is a Director at Nexawell Pharma Private Limited (since 2026).

DIN 11533153
Primary Designation Director
First Appointment 09 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nexawell Pharma Private Limited U21004GJ2026PTC173250
Director09 Feb 20262026Active

Board colleagues of Nevilkumar Pratapbhai Mori

NameDINCompanyDesignation
Kuldip Ukabhai Dodiya11533152Nexawell Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nexawell Pharma Private Limited
Premium access

Shareholding and investment profile for Nevilkumar Pratapbhai Mori

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nevilkumar Pratapbhai Mori

Nevilkumar Pratapbhai Mori currently holds 1 directorship: Nexawell Pharma Private Limited (Director, since 09 Feb 2026).

Nevilkumar Pratapbhai Mori was first appointed on 09 Feb 2026 as Director at Nexawell Pharma Private Limited.

The current boards of Nevilkumar Pratapbhai Mori's companies include Kuldip Ukabhai Dodiya (Nexawell Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available